CD8 T cell responses to particular JCV epitopes were found to be associated with longer survival times after early PML in HIV-positive subjects [15], and a recent study showed that CD4 and CD8 T cell responses to JCV were more likely to be detected in PML survivors than in PML progressors [16]. This evidence concerns the gene CD8A and progressive multifocal leukoencephalopathy.